Back
Adaptimmune Therapeutics PLC Vs. NuCana PLC Industry Stock Comparison
Sell
29
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.80
Seasonality Move:
35.83%
Sell
45
NCNA
NuCana PLC
Last Price:
1.50
Seasonality Move:
20.27%
Sell
29
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.80. The Score for ADAP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
NuCana PLC (NCNA)
is a Sell
Is NuCana PLC a Buy, Sell or Hold?
- The current NuCana PLC [NCNA] share price is $1.51. The Score for NCNA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NCNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NCNA Stock Price Chart
What is NuCana PLC's stock price today?
-
The NuCana PLC share price today is $1.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing slight selling pressure.
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 44.32 | Sell |
| Chaikin Money Flow: | 606950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.75 - 0.89) | Sell |
| Bollinger Bands (100): | (0.86 - 1.2) | Sell |
NCNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 32.8 | Sell |
| Chaikin Money Flow: | -65447 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.6 - 2.02) | Sell |
| Bollinger Bands (100): | (1.54 - 4.92) | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.78 | Buy |
| 20-day SMA: | 0.8 | Sell |
| 50-day SMA: | 0.93 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.79 | Buy |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.9 | Sell |
| 200-day EMA: | 1.03 | Sell |
NCNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.56 | Sell |
| 20-day SMA: | 1.74 | Sell |
| 50-day SMA: | 2.5 | Sell |
| 200-day SMA: | 4.54 | Sell |
| 8-day EMA: | 1.57 | Sell |
| 20-day EMA: | 1.79 | Sell |
| 50-day EMA: | 2.45 | Sell |
| 200-day EMA: | 5.3 | Sell |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
NuCana PLC Earnings Growth & NCNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.56 per share, and an increase next year of $0.19 per share.
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NuCana PLC Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||